Skip to content

Awridian Ltd

A Drug Discovery Consultancy

  • Home
  • Services
  • Resources
  • Goals
  • Publications
  • About
  • Compound Library
Posted on 23/10/202323/10/2023 by admin

BOS Manchester 2023

Duncan the CEO of Awridian Ltd will be attending BOS2023 on 28th and 29th November, Manchester Central! He will be chairing a session entitled: OUTSOURCING CASE STUDIES ay 11.30 on the 29th. Look forward to seeing you there.

https://www.bio2bevents.com/bosmanchester2023

Post navigation

Previous PostPrevious SMR RSC RECENT TRENDS IN MEDICINAL CHEMISTRY AND ENABLING TECHNOLOGIES
Next PostNext BMCS Conformational Design in Drug Discovery 2024

Recent Posts

  • 37th BMCS Spring Symposium on Medicinal Chemistry
  • SMR: TARGET IDENTIFICATION AND VALIDATION IN DRUG DISCOVERY
  • March 2025
  • BOS Manchester 2024
  • BMCS Conformational Design in Drug Discovery 2024

Recent Comments

    Archives

    • February 2026
    • October 2025
    • March 2025
    • October 2024
    • March 2024
    • October 2023
    • October 2022
    • July 2022
    • February 2022
    • February 2021
    • January 2021
    • February 2020
    • January 2020
    • October 2019
    • August 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Search Awridian

    News

    • 37th BMCS Spring Symposium on Medicinal Chemistry 26/02/2026
    • SMR: TARGET IDENTIFICATION AND VALIDATION IN DRUG DISCOVERY 19/10/2025
    • March 2025 17/03/2025
    • BOS Manchester 2024 14/10/2024
    • BMCS Conformational Design in Drug Discovery 2024 04/03/2024
    Privacy Policy and Cookies Proudly powered by WordPress